Warning letter
Boca Pharmacal Inc.: warning letter of Oct 11, 2002
FDA warning letter UCM145170 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM145170 |
|---|---|
| Company | Boca Pharmacal Inc. |
| Subject | Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin |
| Issue date | Oct 11, 2002 |
| Posted date | Oct 11, 2002 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 341 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: